Mark Pegram, MD
Mark Pegram, MD, is the Suzy Yuan-Huey Hung Endowed Professor of Medical Oncology at the Stanford University School of Medicine, as well as associate dean for clinical research quality. He is also the medical director of the Stanford Clinical Translational Research Unit, which specializes in first-in-human Phase 1 clinical trials. Pegram’s breast cancer research focuses on the cancer-associated gene that encodes HER2 and on developing novel therapies for HER2-positive metastatic breast cancer.